Two new cost-effective ways to predict prostate cancer

Two related studies reveal new risk indicators for prostate cancer. The first study shows that men diagnosed with benign prostate enlargement have an increased risk of developing and dying from prostate cancer. The second study shows that monitoring prostate-specific antigen levels can be used to predict the long-term risk of healthy men developing and dying from prostate cancer. Both could lead to more efficient and cost-effective screening for prostate cancer, with reductions in over-diagnosis and unnecessary treatment.

Read the whole article on Science Daily

More from Science Daily